Navigation Links
Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops
Date:12/10/2008

g; brand hybrids with herbicide tolerance are averaging 7.1 bushels per acre better than competitive hybrids with herbicide tolerance. On-farm soybean yield trials are showing an overall Pioneer advantage of 1.3 bushels per acre. Key soybean products, which include the new Pioneer® Y Series soybeans, are demonstrating as much as a 3.8 bushel advantage over competitors.

“The responses we are seeing from existing Pioneer customers in the form of early seed orders for 2009 is proof that our leading technology, superior agronomic performance and unmatched customer service are the real triple-stack of the day,” said Niebur. Customer orders to date are up more than 15 percent over the same period last year.”

Pioneer Hi-Bred, a DuPont business, is the world’s leading source of customized solutions for farmers, livestock producers and grain and oilseed processors. With headquarters in Des Moines, Iowa, Pioneer provides access to advanced plant genetics in nearly 70 countries.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

12/10/08

The DuPont Oval Logo, DuPont™, The miracles of science™ and Pioneer® are registered trademarks or trademarks of DuPont or its affiliates.

###

Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related biology technology :

1. LI-COR Biosciences Offers $1.75 Million in Matching Funds for Undergraduate Genomics Education
2. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
3. Align Technology Receives Expanded Regulatory Approval in Japan
4. Genome Technology Names 2008 Tomorrows PIs
5. BioWa Licenses POTELLIGENT(R) Technology to GlaxoSmithKline for Use in Antibody Development and Commercialization
6. J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology
7. Imaging Diagnostic Systems CT Laser Mammography (CTLM) Technology Featured in Peer-Reviewed Journal
8. Technology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones in Alzheimers Disease Drug Development
9. Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research
10. eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008
11. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops
(Date:7/29/2014)... , July 29, 2014  Discovery Laboratories, ... to advancing a new standard of respiratory critical ... on August 5, 2014 before the open of ... Company will host a live teleconference and webcast ... the conference call, Discovery Labs, management will discuss ...
(Date:7/29/2014)... 29, 2014  Cannabis Science, Inc. (OTC: CBIS), ... development and related consulting, applauds the Editorial Board ... strong position in opposition to current federal law ... publication.  The New York Times also announces a ... exploring the issue called "High Time:  An Editorial ...
(Date:7/29/2014)... & Rockville, MD (PRWEB) July 29, 2014 ... Inc. (ITI), a vaccine pioneer in the biotechnology ... services firm Newport Coast Securities, Inc. to explore ... is commercializing LAMP-vax technology, a breakthrough vaccine platform ... and immunotherapy market. The company exclusively licensed the ...
(Date:7/29/2014)... , July 29, 2014  Sigma-Aldrich Corporation (NASDAQ: ... and energy use, increased its investment in Green Chemistry ... around the world last year, the Company announced Monday ... if Science Changed the World? The ... several honors for being a responsible corporate citizen, including ...
Breaking Biology Technology:Discovery Labs to Report 2014 Second Quarter Financial Results and Hold Conference Call on Tuesday, August 5, 2014 at 9:00 a.m. Eastern Time 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 2Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 3Immunomic Therapeutics Engages Newport Coast Securities, Inc. 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 3Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 2Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 3
... , SAN MARINO, Calif., Aug. 7 ... a wholly owned subsidiary called MetaCytoLytics, Inc. This company was ... Professor M. Karen Newell called "metabolic disruption technology" (MDT), which ... from glucose or from fatty acids. That process has ...
... Aug. 6 AutoImmune Inc. (OTC Bulletin Board: AIMM) today reported ... diluted, for the three months ended June 30, 2009, compared with ... diluted, for the three months ended June 30, 2008. For the ... or $0.02 per share basic and diluted, compared with net loss ...
... ROCKVILLE, Md., Aug. 6 Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: ... and commercialization of clinical-stage product candidates for central nervous system disorders, ... 30, 2009, on Monday, August 10, 2009, before the market opens. ... that time. , , Mihael H. Polymeropoulos, M.D., ...
Cached Biology Technology:Viral Genetics Creates Subsidiary to Develop Cancer Therapy 2Viral Genetics Creates Subsidiary to Develop Cancer Therapy 3Viral Genetics Creates Subsidiary to Develop Cancer Therapy 4AutoImmune Inc. Reports 2009 Second Quarter Financial Results 2AutoImmune Inc. Reports 2009 Second Quarter Financial Results 3AutoImmune Inc. Reports 2009 Second Quarter Financial Results 4AutoImmune Inc. Reports 2009 Second Quarter Financial Results 5Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009 2
(Date:7/29/2014)... Achalasia is a rare disease it affects 1 in ... in the esophageal wall. While its cause remains unknown, a ... in Belgium, the University of Bonn in Germany and other ... autoimmune in origin. The study, published on 6 July in ... the mysterious disease. , When we swallow, a sphincter in ...
(Date:7/28/2014)... communities showing signs of damage from the Deepwater Horizon oil ... the Gulf of Mexico. The discovery was made by a ... State University. A paper describing this work and additional impacts ... will be published during the last week of July 2014 ... of the National Academy of Sciences . , "The footprint ...
(Date:7/28/2014)... Ariz. - Reactions among minerals and organic compounds in ... carbon cycle, they provide energy for the deep biosphere, ... However, very little is known about how minerals influence ... State University have demonstrated how a common mineral acts ... negating the need for toxic solvents or expensive reagents. ...
Breaking Biology News(10 mins):Mysterious esophagus disease is autoimmune after all 2Impact of Deepwater Horizon oil spill on coral is deeper and broader than predicted 2Mineral magic? Common mineral capable of making and breaking bonds 2Mineral magic? Common mineral capable of making and breaking bonds 3
... Two inventions created by University of Texas Medical Branch ... Texas Ignition Fund, a new program designed to spur ... One of the inventions, conceived by UTMB anesthesiology ... to deliver precise amounts of fluids to trauma and ...
... Beijing Genomics Institute announced today that BGI has added ... sequencing technologies. Two AB SOLiD Systems have been ... The AB SOLiD System generated high-throughput high quality mate-pair ... The highest throughput reached so far is 6.8 ...
... discovered that increasing age affects the way breast cancer behaves. ... likely to be diagnosed with aggressive tumours that have spread ... increasingly likely to spread, particularly if the tumours are small. ... and lymph node involvement and this study is the first ...
Cached Biology News:UTMB inventions win University of Texas System commercialization awards 2Breast cancers behave differently before and after the age of 70 2Breast cancers behave differently before and after the age of 70 3
... Avian Myeloblastosis Virus Reverse Transcriptase (AMV ... template DNA, RNA or RNA:DNA hybrids (1). ... more efficient than RNA primers) as well ... an intrinsic RNase H activity. Both nonionic ...
DNase I (Deoxyribonuclease I) digests single- and double-stranded DNA to oligodeoxyribonucleotides. Ribonuclease activity has been reduced to non-detectable levels....
... RQ1 RNase-Free DNase is a preparation ... or double-stranded DNA to produce 3-hydroxyl ... use in applications where maintaining the ... DNase is qualified for use with ...
... I, Wild Type Liquid. In 100 ... 200 µM EDTA, 20% glycerol, pH 7.9. AVOID ... is a monomeric protein of 765 amino acids ... relaxation of both positive and negative supercoiled DNAs ...
Biology Products: